Clinical Trial Update: A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study- [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2/3 study evaluating the efficacy and safety of DE-117 ophthalmic solution in adults with primary o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DE-117 Ophthalmic Solution (DE-117)

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2, Phase 3 | Status: COMPLETED